Do Digital Health Technologies Hold Promise for Preventing Progression to Type 2 Diabetes?
The Journal of Clinical Endocrinology & Metabolism · 2024
DOI: 10.1210/clinem/dgae020 ↗Kurz gefasst
Editorial in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2024. Verfasst von Tomoya Mita. Beteiligte Einrichtung: Department of Metabolism & Endocrinology, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Disease Progression. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 8 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Metabolism & Endocrinology, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
ORCID-Profile: Tomoya Mita
Zitieren
APA
Mita, T. (2024). Do Digital Health Technologies Hold Promise for Preventing Progression to Type 2 Diabetes?. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae020
Vancouver
Mita T. Do Digital Health Technologies Hold Promise for Preventing Progression to Type 2 Diabetes?. The Journal of Clinical Endocrinology & Metabolism. 2024. doi:10.1210/clinem/dgae020
BibTeX
@article{Mita2024,
author = {Mita, Tomoya},
title = {Do Digital Health Technologies Hold Promise for Preventing Progression to Type 2 Diabetes?},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2024},
doi = {10.1210/clinem/dgae020}
}
EUVIMED